X-linked development defects of myelination: From mouse mutants to human genetic diseases

Neuroscientist

Volumn 2, Issue 1, 1996, Pages 33-43

  Nave, Klaus Armin ^a   Boespflug Tanguy, Odile ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSERM   (France)

Author keywords

Gene dosage effects; Glial cell death; Mouse mutants; Pelizaeus Merzbacher disease; Proteolipid protein gene; Spastic paraplegia; Transgenic mice

Indexed keywords

EID: 0002768920     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200111     Document Type: Review

References (80)

1. Pelizaeus F. Über eine eigenthümliche Form spastischer Lähmung mit Cerebral erscheinungen auf hereditärer Grundlage (Multiple Sklerose). Arch Psychiat Nervenkr 1885;16:698-710.
2. Merzbacher L. Eine eigenartige familiäre Erkrankungsform (Aplasia axialis extracorticolis congenita). Z ges Neurol Psychiat 1910;3:1-138.
3. Seitelberger F. Pelizaeus-Merzbacher disease. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Vol. 10. Amsterdam: North Holland 1970;150-202.
4. Boulloche J, Aicardi J. Pelizaeus-Merzbacher disease: clinical and nosological study. J Child Neurol 1986;1:233-239.
5. Wilkus RJ, Farrell D. Electrophysiologic observations in the classical form of Pelizaeus-Merzbacher disease. Neurology 1976; 26:1042-1045.
6. Apkarian P, Koetsveld-Baart JC, Barth PG. Visual evoked potential characteristics and early diagnosis of Pelizaeus-Merzbacher disease. Arch Neurol 1993;50:981-985.
7. Caro PA, Marks HG. Magnetic resonance imaging and computed tomography in Pelizaeus-Merzbacher disease. Magn Reson Imag 1990;8:8128-8131.
8. Ono J, Harada K, Sakurai K, et al. MR diffusion imaging in Pelizaeus-Merzbacher disease. Brain Dev 1994;16:219-223.
9. Lees M, Brostoff SL. Proteins of myelin. In: Morell P, editor. Myelin. 2nd ed. New York: Plenum Press 1984;197-224.
10. Milner RJ, Lai C, Nave K-A, Lenoir D, Ogata J, Sutcliffe JG. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 1985;42:931-939.
11. Nave K-A, Lai C, Bloom FE, Milner RJ. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A 1987;84:5665-5669.
12. Popot JL, Pham-Dinh D, Dautigny A. Major myelin proteolipid: the 4-a-helix topology. J Membr Biol 1991;120:233-246.
13. Weimbs T, Stoffel W. Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 1992;31:12289-12296.
14. Duncan ID, Hammang JP, Goda S, Quarles RH. Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 1989;2:148-154.
15. Boisson D, Stoffel W. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci U S A 1994;91:11709-11713.
16. Pucket C, Hudson L, Ono K, et al. Myelin specific proteolipid protein is expressed in myelinating Schwann cells but not incorporated into myelin sheaths. J Neurosci Res 1987;18:511-518.
17. Willard HF, Riordan JR. Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science 1985;230:940-942.
18. Mattei MG, Alliel PM, Dautigny A, et al. The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome. Hum Genet 1986;72:352-353.
19. Cremers FPM, Pfeiffer R, van de Pol TJR, et al. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum Genet 1987;77:23-27.
20. Diehl H-J, Schaich M, Dudzinski R-M, Stoffel W. Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc Natl Acad Sci U S A 1986;83: 9807-9811.
21. Pham-Dinh D, Birling MC, Roussel G, Dautigny A, Nussbaum JL. Proteolipid DM-20 predominates over PLP in peripheral nervous system. Neuroreport 1991a;2:89-92.
22. Timsit SG, Bally-Cuif L, Colman DR, Zalc B. DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J Neurochem 1992;58:1172-1175.
23. Ikenaka K, Kagawa T, Mikoshiba K. Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J Neurochem 1992;58:2248-2253.
24. Wight PA, Duchala CS, Readhead C, Macklin WB. A myelin proteolipid-lacZ, fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J Cell Biol 1993;123:443-454.
25. Readhead C, Schneider A, Griffiths I, Nave K-A. Premature arrest of myelin formation in transgenic mice with increased proteolipoprotein gene dosage. Neuron 1994;12:583-595.
26. Nadon NL, Arnheiter H, Hudson LD. A combination of PLP and DM-20 transgenes promotes partial myelination in the jimpy mouse. J Neurochem 1994;63:822-833.
27. Kagawa T, Ikenaka K, Inoue Y, et al. Glial cell degeneration and hypomyelination caused by overexpression of the myelin proteolipid protein gene. Neuron 1994;13:427-442.
28. Yan Y, Lagenaur C, Narayanan V. Molecular cloning of M6: identification of a PLP/DM-20 gene family. Neuron 1993;11:423-431.
29. Kitagawa K, Sinoway MP, Yang C, Gould RM, Colman DR. A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptides. Neuron 1993;11:433-448.
30. Nave K-A. Neurological mouse mutants and genes of myelin. J Neurosci Res 1994;38:607-612.
31. Sidman RL, Dickie, MM, Appel SH. Mutant mice (quaking and jimpy) with deficient myelination in the central nervous system. Science 1964;144:309-311.
32. Boison D, Stoffel W. Myelin-deficient rat: a point mutation in exon III (A→C, Thr75→Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. EMBO J 1989;8:3295-3302.
33. Nadon NL, Duncan ID, Hudson LD. A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development. Development 1990;110:529-537.
34. Rosenbluth J, Hasegawa M. Spinal cord lesions block seizures or delay their onset in myelin-defident rats: evidence that generalized tonic seizures can be triggered by abnormal spinal cord activity. Exp Neurol 1989;103:154-157.
35. Young W, Rosenbluth J, Wojak JC, Sakatani K. Extracellular potassium activity and axonal conduction in spinal cord of the myelin-deficient mutant rat. Exp Neurol 1989;106:41-51.
36. Utzschneider D, Black JA, Kocsis JD. Conduction properties of spinal cord axons in the myelin-deficient rat mutant. Neuroscience 1992;49, 221-228.
37. Schneider A, Montague P, Griffiths IR, et al. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 1992;358:758-761.
38. Johnston AW, MacKusick VA. A sex-linked recessive form of spastic paraplegia. Am J Hum Genet 1962;14:83-94.
39. Kobayashi H, Hoffman E, Marks H. The rumpshaker mutation in spastic paraplegia. Nat Genet 1994;7:351-352.
40. Tosic M, Dolivo M, Domanska-Janik K, Matthieu JM. Paralytic tremor (pt): a new allele of the proteolipid protein gene in rabbits. J Neurochem 1994;63:2210-2216.
41. Raskind WH, Williams CA, Hudson LD, Bird TD. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Med Genet 1991;49:1355-1360.
42. Nave K-A, Lai C, Bloom FE, Milner RJ. jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci U S A 1986;83:9264-9268.
43. Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci USA 1987;84:1454-1458.
44. msd mice. J Neurosci 1990;10:117-124.
45. Knapp PE, Skoff RP, Redstone DW. Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit. J Neurosci 1986;6:2813-2822.
46. Vermeesch MK, Knapp PE, Skoff RP, Studzinski DM, Benjamins, JA. Death of individual oligodendrocytes in jimpy brain precedes expression of proteolipid protein. Dev Neurosci 1990;12:303-315.
47. Skoff RP. Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res 1982;248:19-31.
48. Knapp PE, Skoff RP. A defect in the cell cycle of neuroglia in the myelin deficient jimpy mouse. Dev Brain Res 1987;35:301-306.
49. Meier C, Bischoff A. Dysmyelination in "jimpy" mouse. J Neuropathol Exp Neurol 1974;33:343-353.
50. Lachapelle F, Gumpel M, Baumann N. Contribution of transplantations to the understanding of the role of the PLP gene. Neurochem Res 1994;19:1083-1090.
51. Bartlett WP, Knapp PE, Skoff RP. Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes. Glia 1988;1:253-259.
52. Gow A, Friedrich VL, Lazzarini RA. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 1994;37:574-583.
53. Jung M, Schneider A, Nave KA. Dominant-negative action of mutations in the PLP/DM-20 gene and direct interaction of PLP polypeptides in vivo. J Neurochem 1995;64:5101.
54. Schneider A, Griffiths IR, Readhead C, Nave K-A. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci U S A 1995;92:4447-4451.
55. Simons-Johnson R, Roder JC, Riordan JR. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem 1995;64:967-976.
56. Snipes GJ, Suter LJ, Shooter E. The genetics of myelin. Curr Opin Neurobiol 1993;3:694-702.
57. Koeppen AH, Ronca NA, Greenfield EA, Hans MB. Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacber disease. Ann Neurol 1987;21:159-170.
58. Pham-Dinh D, Boespflug-Tanguy O, Mimault C, et al. Pelizaeus-Merzbacher disease: a frameshift deletion/insertion event in the myelin proteolipid gene. Hum Mol Genet 1993;4:465-467.
59. Kleindorfer DO, Dlouhy SR, Pratt VM, Jones MC, Trofatter JA, Hodes ME. In-frame deletion in the proteolipid protein gene in a family with Pelizaeus-Merzbacher disease. Am J Med Genet 1995;55:405-407.
60. Bridge PJ, Wilkins PJ. The role of proteolipid protein in gene mutations in Pelizaeus-Merzbacher disease. Am J Hum Genet 1992;209:823.
61. Ellis D, Malcom S. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nat Genet 1994;6:333-334.
62. Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 1994;15:383-394.
63. Hudson LD, Puckett C, Berndt J, Chan J, Gencic S. Mutation of the proteolipid protein gene (PLP) in a human X chromosome-linked disorder. Proc Natl Acad Sci USA 1989;86:8128-8131.
64. Boespflug-Tanguy O, Mimault C, Melki J, et al. Genetic homogeneity of Pelizaeus-Merzbacher Disease (PMD): tight linkage to the proteolipoprotein (PLP) locus in 16 affected families Am J Hum Genet 1994;55:461-467.
65. Jouet M, Rosenthal A, Armstrong G, et al. X-linked spastic paraplegia (SPG1), Masa syndrome and X-linked hydrocephalus result from mutations in the L1. gene. Nat Genet 1994;7:402-407.
66. Saugier-Veber P, Munnich A, Bonneau D, et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 1994;6:257-261.
67. Trofatter JA, Dlouhy SR, DeMeyer W, Coneally PM, Hodes ME. Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc Natl Acad Sci USA 1989;86:9427-9430.
68. Dlouhy SR, Pratt VM, Boyadjiev S, Hodes MH. Pelizaeus-Merzbacher caused by de novo mutation. J Neuropathol Exp Neurol 1993;52:331.
69. Doll R, Natowicz MR, Schiffmann R, Smith FI. Molecular diagnostics for myelin proteolipid gene mutations in Pelizaeus-Merzbacher disease. Am J Hum Genet 1992;51:161-169.
70. Nance MA, Pratt VM, Boyadjiev S, Hodes ME. Adult onset neurological disorder in Pelizaeus-Merzbacher disease carrier mother. Abstract. Am J Hum Genet 1993;53:1745.
71. Pratt VM, Naidu S, Dlouhy SR, Marks HG, Hodes ME. A novel mutation in exon 3. of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 1995a;45:394-395.
72. Weimbs T, Dick T, Stoffel W, Boltshauser E. A point mutation at the X-chromosomal proteolipid protein locus in Pelizaeus-Merzbacher disease leads to disruption of myelinogenesis. Biol Chem Hoppe Seyler 1990;371:1175-1183.
73. Pratt VM, Kiefer JR, Lähdetie J, Schleutker J, Hodes ME, Dlouhy SR. Linkage of a new mutation in the proteolipid protein (PLP) gene to Pelizaeus-Merzbacher disease (PMD) in a large Finnish kindred. Am J Med Genet 1993;52:1053-1056.
74. 223-Pro in the proteolipid protein gene, and prenatal diagnosis. Am J Hum Genet 1992;51:871-878.
75. 206-Cys mutation in the proteolipid protein causes Pelizaeus-Merzbacher disease. Am J Hum Genet 1991;972:183.
76. Gencic S, Abuelo D, Ambler M, Hudson LD. Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet 1989;45:435-442.
77. Pratt VM, Boyadjiev S, Dlouhy SR, Silver K, DerKaloustian VM, Hodes ME. Pelizaeus-Merzbacher disease in a family of Portuguese origin caused by a point mutation in exon 5. of the proteolipid protein gene. Am J Med Genet 1995b;55:402-404.
78. Pham-Dinh D, Popot JL, Boespflug-Tanguy O, et al. Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid. Proc Natl Acad Sci U S A 1991b;88:7562-7566.
79. Iwaki A, Muramoto T, Iwaki T, et al. A missense mutation in the proteolipid protein gene responsible for Pelizaeus-Merzbacher disease in a Japanese family. Hum Mol Genet 1993;2:19-22.
80. Kurosawa K, Iwaki A, Miyake S, Imaizumi K, Kuroki Y, Fukumaki Y. A novel insertional mutation at exon VII of the myelin proteolipid protein gene in Pelizaeus-Merzbacher disease. Hum Mol Genet 1993;2:2187-2189.